Indivior Pharmaceuticals, Inc. Share Price
Stocks
INDV
US45579U1097
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.45 USD | 0.00% |
|
-1.17% | +12.74% |
| 29/06 | Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Value-Defensive Index | CI |
| 29/06 | Indivior Pharmaceuticals, Inc.(NasdaqGS:INDV) added to Russell 2000 Growth-Defensive Index | CI |
| Market Cap | 493.17Cr 432.12Cr 401.16Cr 368.63Cr 694.62Cr 48TCr 704.85Cr 4.78TCr 1.87TCr 23TCr 1.85TCr 1.81TCr 80TCr | P/E 2026 * |
12.7x | P/E 2027 * | 11.2x |
|---|---|---|---|---|---|
| Enterprise Value | 498.62Cr 436.89Cr 405.59Cr 372.7Cr 702.3Cr 48TCr 712.63Cr 4.83TCr 1.89TCr 24TCr 1.87TCr 1.83TCr 81TCr | EV / Sales 2026 * |
3.96x | EV / Sales 2027 * | 3.45x |
| Free-Float |
97.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Indivior Pharmaceuticals, Inc.
| 1 week | -1.17% | ||
| Current month | -1.41% | ||
| 1 month | +5.56% | ||
| 3 months | +21.14% | ||
| 6 months | +20.60% | ||
| Current year | +12.74% |
| 1 week | 38.56 |  | 41.01 |
| 1 month | 38.56 | | 42.81 |
| Current year | 27.68 | | 42.81 |
| 1 year | 16.59 | | 42.81 |
| 3 years | 7.33 | | 42.81 |
| 5 years | 7.33 | | 42.81 |
| 10 years | 1.75 | | 42.81 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/07/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% | ||
| 22/06/26 | Fiscal year | Chief Executive Officer | 31,46,355 | 2.5806% | ||
| 11/06/26 | Sell | Chief Scientific Officer | -18,586 | 0.0152% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -1.17% | +150.00% | +67.63% | 493.17Cr | |
| -1.05% | +0.55% | +49.79% | +151.71% | 1,03700Cr | |
| +2.00% | +3.49% | +52.22% | +50.20% | 62TCr | |
| -1.09% | +3.76% | +35.37% | +76.22% | 45TCr | |
| -0.42% | +0.67% | +30.81% | +21.05% | 33TCr | |
| -0.16% | +2.74% | +36.02% | +37.33% | 29TCr | |
| +1.68% | +1.08% | +22.70% | +17.94% | 26TCr | |
| -1.40% | -3.34% | -24.63% | -42.39% | 22TCr | |
| -0.05% | +2.16% | +19.75% | +55.89% | 20TCr | |
| +0.05% | -1.03% | +18.31% | +61.63% | 16TCr | |
| Average | -0.25% | +0.89% | +39.03% | +49.72% | 35.62TCr | |
| Weighted average by Cap. | -0.46% | +1.47% | +36.06% | +72.16% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 126.01Cr 110.41Cr 102.5Cr 94Cr 177.48Cr 12TCr 180.09Cr 1.22TCr 477.92Cr 5.95TCr 473.03Cr 462.83Cr 21TCr | 131.24Cr 115Cr 106.76Cr 98Cr 184.85Cr 13TCr 187.57Cr 1.27TCr 497.77Cr 6.2TCr 492.68Cr 482.06Cr 21TCr |
| Net income | 41Cr 36Cr 34Cr 31Cr 58Cr 4TCr 59Cr 401.63Cr 157.19Cr 1.96TCr 155.59Cr 152.23Cr 6.76TCr | 47Cr 41Cr 38Cr 35Cr 67Cr 4.56TCr 68Cr 458.22Cr 179.34Cr 2.23TCr 177.51Cr 173.68Cr 7.71TCr |
| Net Debt | 5.45Cr 4.78Cr 4.43Cr 4.07Cr 7.68Cr 525.9Cr 7.79Cr 53Cr 21Cr 257.33Cr 20Cr 20Cr 888.94Cr | -40Cr -35Cr -33Cr -30Cr -57Cr -3.89TCr -58Cr -390.9Cr -153Cr -1.9TCr -151.43Cr -148.17Cr -6.58TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/26/22 | $40.45 | 0.00% | 9,68,100 |
| 21/26/21 | $40.45 | +3.40% | 18,40,381 |
| 20/26/20 | $39.12 | -3.50% | 25,40,765 |
| 17/26/17 | $40.54 | -0.12% | 9,84,698 |
| 16/26/16 | $40.59 | -0.83% | 17,46,666 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INDV Stock
Select your edition
All financial news and data tailored to specific country editions
